Anti-CTLA-8 / IL-17a Reference Antibody (secukinumab)
- Product Code: 139982
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in the treatment of autoimmune diseases such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by neutralizing interleukin-17A, a key cytokine involved in inflammatory pathways, thereby reducing inflammation and disease symptoms. Commonly administered via subcutaneous injection, it helps improve skin clearance, joint function, and quality of life in affected patients.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-CTLA-8 / IL-17a Reference Antibody (secukinumab)
Used in the treatment of autoimmune diseases such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by neutralizing interleukin-17A, a key cytokine involved in inflammatory pathways, thereby reducing inflammation and disease symptoms. Commonly administered via subcutaneous injection, it helps improve skin clearance, joint function, and quality of life in affected patients.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :